Huynh Faith D, Damiani Giovanni, Bunick Christopher G
Yale School of Medicine, New Haven, CT 06510, USA.
Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20122 Milan, Italy.
Antibiotics (Basel). 2024 Mar 17;13(3):268. doi: 10.3390/antibiotics13030268.
Hidradenitis suppurativa (HS), or acne inversa, is a chronic inflammatory dermatological condition characterized by painful and recurrent nodules and purulent abscesses. HS can have a devastating impact on the quality of life of patients. This condition is commonly localized to the axilla, groin, perineal, and inframammary regions, and can develop fistulas and sinus tracts over time. Its pathogenesis remains elusive and is best characterized at the moment as multi-factorial. Additionally, questions remain about the role of cutaneous dysbiosis as a primary HS trigger or as a secondary perturbation due to HS inflammation. This article features works in relation to HS and its interplay with bacterial microflora. We address current treatment approaches and their impact on HS-related bacteria, as well as areas of therapeutic innovation. In the future, disease-modifying or remittive therapy will likely combine an advanced/targeted anti-inflammatory approach with one that effectively modulates cutaneous and deep tissue dysbiosis.
化脓性汗腺炎(HS),又称反向性痤疮,是一种慢性炎症性皮肤病,其特征为疼痛性复发性结节和脓性脓肿。HS会对患者的生活质量产生毁灭性影响。这种病症通常局限于腋窝、腹股沟、会阴和乳房下区域,随着时间的推移会形成瘘管和窦道。其发病机制仍不清楚,目前最恰当的描述是多因素的。此外,关于皮肤微生物失调是作为HS的主要触发因素还是由于HS炎症引起的继发性扰动,仍存在疑问。本文介绍了与HS及其与细菌微生物群相互作用相关的研究成果。我们讨论了当前的治疗方法及其对与HS相关细菌的影响,以及治疗创新领域。未来,疾病改善或缓解疗法可能会将先进/靶向抗炎方法与有效调节皮肤和深部组织微生物失调的方法相结合。